基因型对Candida glabrata血流感染预后的影响
Pao-Yu Chen1,2, Yu-Shan Huang1,2, Yu-Chung Chuang1
1Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
The Journal of antimicrobial chemotherapy
|June 21, 2024
概括
在Candida glabrata血流感染 (BSI) 的基因型鉴定中,CC7被确定为主要的基因型. 这种基因型与伴随性疾病患者的较高死亡率有关.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 遗传学 是一个遗传学.
背景情况:
- 像Candida glabrata这样的病原体的基因定型可以揭示独特的耐药性,毒性和结果模式.
- 将Candida glabrata基因型与临床结果联系在一起的证据有限.
- 这项研究调查了Candida glabrata基因型在血液感染 (BSI) 中的临床和真菌学相关性.
研究的目的:
- 描述Candida glabrata血流感染 (BSI) 中基因型的临床和真菌学意义.
- 为了确定特定的基因型是否与患者的结果或抗真菌耐药性有关.
主要方法:
- 多部位序列类型化 (MLST) 用于对48个非重复的Candida glabrata血液分离物进行基因型.
- 用UPGMA将分离物聚集成克隆复合体 (CCs).
- 进行了抗真菌敏感性测试,并分析了临床数据以查找结果关联.
主要成果:
- 确定了13种序列类型 (ST),其中CC7是最常见的 (29.2%).
- 在CC7或其他CC与抗真菌耐药性之间没有发现显著的关联.
- 查尔森并发症指数预测了CC7的BSI风险. CC7独立地与28天死亡率的增加有关.
结论:
- 患有并发症的患者患CC7 Candida glabrata BSIs的风险更高.
- CC7基因型是患有C. glabrataBSI的患者更糟糕的结果的独立预测因素.
- 在这项研究中,抗真菌耐药性没有显著影响死亡率.
相关概念视频
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84


